Impact of the PARO Therapeutic Robot on Quality of Life in Gynecologic Cancer Patients Receiving Chemotherapy at an Outpatient Infusion Center: A Prospective Pilot Study

Service: Trial Number:
Principal Investigator: Conducted at:
Long Beach Medical Center
Currently enrolling additional patients:
Age Range:
18 & older

Gynecologic cancer survivors have been shown to experience significant symptom burden throughout treatment, with common symptoms including pain, fatigue, depression and anxiety. It has been a priority to explore avenues in which these symptoms can be targeted in cancer patients. Complementary therapies are defined as treatments that enhance, support or facilitate conventional treatment strategies. Recently, the PARO therapeutic robot has gained attention following research publications illustrating it’s ability to reduce patient and caregiver stress, stimulate patient interaction, improve patient relaxation, motivation and socialization amongst elderly patients with Alzheimer’s/dementia. We propose to use PARO therapeutic robots to explore their impact on gynecologic oncology cancer patients undergoing chemotherapy treatment. Patients will be assigned to traditional management (i.e. quiet reading, television watching, resting/sleeping, and interaction with family/friends) for one session of chemotherapy to establish a baseline, followed by exposure to a PARO robot that is fully active and functional on their subsequent cycle. All subjects will complete a ten minute questionnaire that assess pain, fatigue, stress level, anxiety, sadness, irritability, calmness, pleasantness and cheerfulness. Results will be analyzed.